Annual Cash & Cash Equivalents
$45.03 M
-$145.58 M-76.37%
December 31, 2023
Summary
- As of February 7, 2025, ATAI annual cash & cash equivalents is $45.03 million, with the most recent change of -$145.58 million (-76.37%) on December 31, 2023.
- During the last 3 years, ATAI annual cash & cash equivalents has fallen by -$52.21 million (-53.69%).
- ATAI annual cash & cash equivalents is now -87.57% below its all-time high of $362.27 million, reached on December 31, 2021.
Performance
ATAI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$29.96 M
+$10.63 M+54.98%
September 30, 2024
Summary
- As of February 7, 2025, ATAI quarterly cash and cash equivalents is $29.96 million, with the most recent change of +$10.63 million (+54.98%) on September 30, 2024.
- Over the past year, ATAI quarterly cash and cash equivalents has dropped by -$46.53 million (-60.83%).
- ATAI quarterly cash and cash equivalents is now -93.39% below its all-time high of $453.62 million, reached on June 30, 2021.
Performance
ATAI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ATAI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.4% | -60.8% |
| 3 y3 years | -53.7% | -75.8% |
| 5 y5 years | +62.5% | -75.8% |
ATAI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.6% | at low | -91.7% | +58.8% |
| 5 y | 5-year | -87.6% | +49.8% | -93.4% | +82.8% |
| alltime | all time | -87.6% | +3047.9% | -93.4% | +413.9% |
Atai Life Sciences NV Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.96 M(+55.0%) |
| Jun 2024 | - | $19.33 M(+2.5%) |
| Mar 2024 | - | $18.87 M(-58.1%) |
| Dec 2023 | $45.03 M(-76.4%) | $45.03 M(-41.1%) |
| Sep 2023 | - | $76.49 M(-45.8%) |
| Jun 2023 | - | $141.09 M(-24.1%) |
| Mar 2023 | - | $185.88 M(-2.5%) |
| Dec 2022 | $190.61 M(-47.4%) | $190.61 M(+33.7%) |
| Sep 2022 | - | $142.54 M(+69.4%) |
| Jun 2022 | - | $84.13 M(-32.1%) |
| Mar 2022 | - | $123.97 M(-65.8%) |
| Dec 2021 | $362.27 M(+272.5%) | $362.27 M(-15.8%) |
| Sep 2021 | - | $430.31 M(-5.1%) |
| Jun 2021 | - | $453.62 M(+334.6%) |
| Mar 2021 | - | $104.37 M(+7.3%) |
| Dec 2020 | $97.25 M(+223.5%) | $97.25 M(+493.4%) |
| Sep 2020 | - | $16.39 M(-2.9%) |
| Jun 2020 | - | $16.88 M(-21.5%) |
| Mar 2020 | - | $21.50 M(-2.5%) |
| Dec 2019 | $30.06 M(+8.5%) | - |
| Dec 2019 | - | $22.04 M(+49.4%) |
| Sep 2019 | - | $14.75 M(-22.8%) |
| Jun 2019 | - | $19.11 M(-23.9%) |
| Mar 2019 | - | $25.13 M(-9.3%) |
| Dec 2018 | $27.71 M(+238.2%) | $27.71 M(-11.1%) |
| Sep 2018 | - | $31.16 M(-28.1%) |
| Jun 2018 | - | $43.33 M(+56.9%) |
| Mar 2018 | - | $27.62 M(+10.8%) |
| Dec 2017 | $8.19 M(-74.6%) | - |
| Sep 2017 | - | $24.94 M(+9.9%) |
| Jun 2017 | - | $22.70 M(-29.7%) |
| Mar 2017 | $32.28 M(-15.7%) | $32.28 M(-9.5%) |
| Dec 2016 | - | $35.67 M(+98.6%) |
| Sep 2016 | - | $17.95 M(-0.2%) |
| Jun 2016 | - | $18.00 M(-53.0%) |
| Mar 2016 | $38.30 M | $38.30 M(-12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $43.70 M(+29.2%) |
| Sep 2015 | - | $33.83 M(-4.6%) |
| Jun 2015 | - | $35.45 M(-8.4%) |
| Mar 2015 | $38.70 M(-23.0%) | $38.70 M(-13.4%) |
| Dec 2014 | - | $44.68 M(+8.5%) |
| Sep 2014 | - | $41.19 M(-24.1%) |
| Jun 2014 | - | $54.28 M(+8.0%) |
| Mar 2014 | $50.27 M(+7.7%) | $50.27 M(-19.4%) |
| Dec 2013 | - | $62.39 M(+34.4%) |
| Sep 2013 | - | $46.42 M(+6.9%) |
| Jun 2013 | - | $43.41 M(-7.0%) |
| Mar 2013 | $46.67 M(+14.6%) | $46.67 M(-1.2%) |
| Dec 2012 | - | $47.25 M(+19.0%) |
| Sep 2012 | - | $39.71 M(-5.5%) |
| Jun 2012 | - | $42.00 M(+3.2%) |
| Mar 2012 | $40.72 M(-0.2%) | $40.72 M(+1.7%) |
| Dec 2011 | - | $40.02 M(+26.2%) |
| Sep 2011 | - | $31.70 M(-28.0%) |
| Jun 2011 | - | $44.02 M(+7.9%) |
| Mar 2011 | $40.81 M(+30.4%) | $40.81 M(+26.5%) |
| Jun 2010 | - | $32.26 M(+3.1%) |
| Mar 2010 | $31.29 M(-31.2%) | $31.29 M(-16.3%) |
| Dec 2009 | - | $37.37 M(+9.0%) |
| Sep 2009 | - | $34.29 M(-22.5%) |
| Jun 2009 | - | $44.25 M(-2.7%) |
| Mar 2009 | $45.49 M(-4.1%) | $45.49 M(-8.9%) |
| Dec 2008 | - | $49.91 M(-2.2%) |
| Sep 2008 | - | $51.03 M(+4.9%) |
| Jun 2008 | - | $48.64 M(+2.5%) |
| Mar 2008 | $47.45 M(+713.8%) | $47.45 M(+678.5%) |
| Dec 2007 | - | $6.10 M(-13.1%) |
| Sep 2007 | - | $7.02 M(+20.3%) |
| Mar 2007 | $5.83 M(+4.6%) | $5.83 M |
| Mar 2006 | $5.57 M(+289.5%) | - |
| Mar 2004 | $1.43 M(-7.9%) | - |
| Dec 2003 | $1.55 M | - |
FAQ
- What is Atai Life Sciences NV annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual cash & cash equivalents year-on-year change?
- What is Atai Life Sciences NV quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly cash and cash equivalents year-on-year change?
What is Atai Life Sciences NV annual cash & cash equivalents?
The current annual cash & cash equivalents of ATAI is $45.03 M
What is the all time high annual cash & cash equivalents for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual cash & cash equivalents is $362.27 M
What is Atai Life Sciences NV annual cash & cash equivalents year-on-year change?
Over the past year, ATAI annual cash & cash equivalents has changed by -$145.58 M (-76.37%)
What is Atai Life Sciences NV quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATAI is $29.96 M
What is the all time high quarterly cash and cash equivalents for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly cash and cash equivalents is $453.62 M
What is Atai Life Sciences NV quarterly cash and cash equivalents year-on-year change?
Over the past year, ATAI quarterly cash and cash equivalents has changed by -$46.53 M (-60.83%)